Dallah Healthcare Company SJSC
SAU:4004

Watchlist Manager
Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC
SAU:4004
Watchlist
Price: 162.2 SAR 0.12%
Market Cap: 15.8B SAR

Intrinsic Value

The intrinsic value of one Dallah Healthcare Company SJSC stock under the Base Case scenario is 131.71 SAR. Compared to the current market price of 162.2 SAR, Dallah Healthcare Company SJSC is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
131.71 SAR
Overvaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dallah Healthcare Company SJSC

What is Valuation History?
Ask AI Assistant
What other research platforms think about Dallah Healthcare Company SJSC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Dallah Healthcare Company SJSC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Dallah Healthcare Company SJSC.

Explain Valuation
Compare Dallah Healthcare Company SJSC to

Fundamental Analysis

Dallah Healthcare Company SJSC
SAU:4004
SA
Health Care
Market Cap
16.4B SAR
IPO
Dec 16, 2012
SA
Health Care
Market Cap
16.4B SAR
IPO
Dec 16, 2012
Price
ï·¼
ï·¼
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about Dallah Healthcare Company SJSC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dallah Healthcare Company SJSC

Current Assets 1.8B
Cash & Short-Term Investments 153.7m
Receivables 1.1B
Other Current Assets 592.3m
Non-Current Assets 7.1B
Long-Term Investments 1.8B
PP&E 4.5B
Intangibles 786.1m
Other Non-Current Assets 1k
Current Liabilities 1.4B
Accounts Payable 412.7m
Accrued Liabilities 271.8m
Short-Term Debt 696.4m
Other Current Liabilities 62.2m
Non-Current Liabilities 3.3B
Long-Term Debt 2.6B
Other Non-Current Liabilities 651.9m
Efficiency

Free Cash Flow Analysis
Dallah Healthcare Company SJSC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dallah Healthcare Company SJSC

Revenue
3.8B SAR
Cost of Revenue
-2.4B SAR
Gross Profit
1.3B SAR
Operating Expenses
-792.4m SAR
Operating Income
554.4m SAR
Other Expenses
-18.8m SAR
Net Income
535.6m SAR
Fundamental Scores

Profitability Score
Profitability Due Diligence

Dallah Healthcare Company SJSC's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Positive 3Y Average ROE
Positive ROE
52/100
Profitability
Score

Dallah Healthcare Company SJSC's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Dallah Healthcare Company SJSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
50/100
Solvency
Score

Dallah Healthcare Company SJSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Dallah Healthcare Company SJSC

Wall Street analysts forecast Dallah Healthcare Company SJSC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dallah Healthcare Company SJSC is 146.81 SAR with a low forecast of 107.06 SAR and a high forecast of 192.15 SAR.

Lowest
Price Target
107.06 SAR
34% Downside
Average
Price Target
146.81 SAR
9% Downside
Highest
Price Target
192.15 SAR
18% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Dallah Healthcare Company SJSC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Dallah Healthcare Company SJSC stock?

The intrinsic value of one Dallah Healthcare Company SJSC stock under the Base Case scenario is 131.71 SAR.

Is Dallah Healthcare Company SJSC stock undervalued or overvalued?

Compared to the current market price of 162.2 SAR, Dallah Healthcare Company SJSC is Overvalued by 19%.

Back to Top